Beta Bionics Inc. share price logo

Beta Bionics Inc. Share Price

NASDAQ: BBNX

Large Cap

$31.41

+1.84

(+6.22%)

as on

Beta Bionics Inc. Stock Performance

as on January 7, 2026 at 2:29 am IST

  • Day's Low

    Day's High

    $29.13
    $31.35
    downward going graph

    7.26%

    Downside

    -0.19%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $8.89
    $32.71
    downward going graph

    71.70%

    Downside

    4.14%

    Upside

    downward going graph

Beta Bionics Inc. share price movements today

Previous Close
$29.57
Open
$29.32
Volume
430.8K
Day's Low - High
$29.13 - $31.35
52 Week Low - High
$8.89 - $32.71

Beta Bionics Inc. Historical Returns

1 Month Return
+ 6.88 %
3 Month Return
+ 41.76 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Beta Bionics Inc. Stock Fundamentals & Key Indicators

Check Beta Bionics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.3B

EPS (TTM)

-1.92

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-47.52%

Beta Bionics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Beta Bionics Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Beta Bionics Inc. image
Beta Bionics Inc.
NA$1.3BNANA-87.89%
Boston Scientific Corp. image
Boston Scientific Corp.
BUY$141.5B167.48%51.0614.43%
Stryker Corporation image
Stryker Corporation
BUY$133.4B50.33%45.8912.07%
Medtronic Plc image
Medtronic Plc
BUY$124.9B-15.49%26.3813.71%
Abbott Laboratories image
Abbott Laboratories
BUY$220.1B14.81%15.5931.88%
See all

Beta Bionics Inc. Stock’s Investor Sentiment and Interest

Search interest for Beta Bionics Inc. Stock has decreased by -23% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-23% versus previous 30 day period

Beta Bionics Inc. Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
3
8
12
15
16
20
17
23
27
Gross Profit
1
5
7
8
8
11
8
12
15
Operating Income
-8
-8
-9
-11
-10
-13
-18
-19
-17
EBITDA
-8
-8
-8
-13
-10
-17
-18
-16
-13
Interest Expense
-
0
-
-
-
0
-
-
-
Depreciation
-
0
0
0
0
0
0
0
0
Income Before Tax
-8
-18
-12
-14
-9
-18
-28
-16
-14
Income Tax Expense
-
-
-
-
-
-
-
-
-
Net Income
-8
-18
-12
-14
-9
-18
-28
-16
-14
Net Profit Margin
-280.63%
-225.72%
-96.26%
-96.13%
-58.28%
-88.59%
-162.46%
-72.59%
-52.14%

Beta Bionics Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2022
Dec 2023
Dec 2024
Total Revenue
0
11
65
Gross Profit
0
6
35
Operating Income
-65
-35
-45
EBITDA
-63
-34
-44
Interest Expense
0
0
-
Depreciation
2
2
2
Income Before Tax
-64
-44
-54
Income Tax Expense
-
-
-
Net Income
-64
-44
-54
Net Profit Margin
-36173.74%
-367.64%
-84.08%

Beta Bionics Inc. Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Net Income
-18
-12
-14
-9
-18
-28
-16
-14
Operating Cash Flow
-6
-12
-12
-9
-14
-19
-13
-8
Investing Cash Flow
-69
7
3
15
-29
-179
6
9
Financing Cash Flow
0
0
0
-1
56
211
0
2
Change in Cash
26
-4
-9
17
12
12
-7
3

Beta Bionics Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2023
Dec 2024
Net Income
-44
-54
Operating Cash Flow
-32
-48
Investing Cash Flow
-69
-3
Financing Cash Flow
101
55
Change in Cash
-1
3

Insights on Beta Bionics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, BBNX stock has moved up by 33.5%

About Beta Bionics Inc.

Beta Bionics, Inc. is a commercial-stage medical device company engaged in the design, development and commercialization of various solutions to improve the health of insulin-requiring people with diabetes (PWD). The Company's product, the iLet Bionic Pancreas (iLet), is an insulin delivery device cleared by the United States Food and Drug Administration (FDA) to utilize adaptive closed-loop algorithms to autonomously determine every insulin dose without requiring a user to count carbohydrate intake. iLet is used for the treatment of Type 1 diabetes (T1D). The Company's solutions include iLet for Adults, iLet for Children, Bionic Circle App and iLet Simulator. The Company is in the early stages of developing an insulin pump that is designed to adhere directly to the skin and administer insulin without the need for tubing, commonly known in the diabetes industry as a patch pump. It is also in the early stages of developing a bihormonal configuration of the iLet.
OrganisationBeta Bionics Inc.
Headquarters11 Hughes, Irvine, CA, United States, 92618
CEOMr. Sean T. Saint PE
E-voting on sharesClick here to vote

Key Management of Beta Bionics Inc.

Name

Title

Ms. Karen Hynes M.B.A.

Vice President of Marketing Execution

Mr. Stephen H. Feider

CFO, Treasurer & Secretary

Mr. David Henderson

Vice President of Operations

Blake Beber

Head of Investor Relations

Mr. Kevin Meinert

Vice President of Legal & Business Development

Dr. Steven Russell M.D., Ph.D.

Chief Medical Officer

Mr. Mike Mensinger

Chief Product Officer

Mr. Sean T. Saint PE

President, CEO & Director

Mr. Mark Hopman M.B.A., R.Ph.

Chief Commercial Officer

FAQs

What is Beta Bionics Inc. share price today?

Beta Bionics Inc. share price today is $31.41 as on at the close of the market. Beta Bionics Inc. share today touched a day high of $31.35 and a low of $29.13.

What is the 52 week high and 52 week low for Beta Bionics Inc. share?

Beta Bionics Inc. share touched a 52 week high of $32.71 on and a 52 week low of $8.89 on . Beta Bionics Inc. stock price today i.e. is closed at $31.41,which is 3.97% down from its 52 week high and 253.32% up from its 52 week low.

What is Beta Bionics Inc.'s market capitalisation today?

Beta Bionics Inc. market capitalisation is $0.00T as on .

How to invest in Beta Bionics Inc. Stock (BBNX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Beta Bionics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Beta Bionics Inc. Shares that will get you 0.0478 shares as per Beta Bionics Inc. share price of $31.41 per share as on January 7, 2026 at 2:29 am IST.

What is the minimum amount required to buy Beta Bionics Inc. Stock (BBNX) from India?

Indian investors can start investing in Beta Bionics Inc. (BBNX) shares with as little as ₹90.143 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹901.43 in Beta Bionics Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Beta Bionics Inc. share’s latest price of $31.41 as on January 7, 2026 at 2:29 am IST, you will get 0.3184 shares of Beta Bionics Inc.. Learn more about fractional shares .